Livzon Pharmaceutical Group Inc (000513) — Cash Flow Quality Index
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Quality Index of 1.80x as of September 2025. Operating cash flow of CN¥853.59 Million exceeds net income of CN¥473.01 Million, indicating high earnings quality where cash backs reported profits. Explore Livzon Pharmaceutical Group Inc (000513) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Livzon Pharmaceutical Group Inc Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for Livzon Pharmaceutical Group Inc across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Livzon Pharmaceutical Group Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Livzon Pharmaceutical Group Inc (1998–2024)
Year-by-year earnings quality comparison for Livzon Pharmaceutical Group Inc. For live market cap and the full company financial profile, see Livzon Pharmaceutical Group Inc market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.29x | CN¥2.98 Billion | CN¥2.30 Billion | ▼ -27.7% |
| 2023 | 1.79x | CN¥3.39 Billion | CN¥1.90 Billion | ▲ +26.2% |
| 2022 | 1.42x | CN¥2.77 Billion | CN¥1.96 Billion | ▲ +45.5% |
| 2021 | 0.97x | CN¥1.90 Billion | CN¥1.95 Billion | ▼ -3.9% |
| 2020 | 1.01x | CN¥2.16 Billion | CN¥2.13 Billion | ▼ -16.2% |
| 2019 | 1.21x | CN¥1.77 Billion | CN¥1.46 Billion | ▲ +12.7% |
| 2018 | 1.07x | CN¥1.27 Billion | CN¥1.18 Billion | ▲ +265.8% |
| 2017 | 0.29x | CN¥1.32 Billion | CN¥4.49 Billion | ▼ -81.0% |
| 2016 | 1.54x | CN¥1.28 Billion | CN¥829.92 Million | ▲ +9.6% |
| 2015 | 1.41x | CN¥927.79 Million | CN¥659.56 Million | ▲ +8.6% |
| 2014 | 1.30x | CN¥717.39 Million | CN¥553.62 Million | ▲ +54.3% |
| 2013 | 0.84x | CN¥439.99 Million | CN¥523.99 Million | ▼ -32.8% |
| 2012 | 1.25x | CN¥593.96 Million | CN¥475.22 Million | ▼ -31.6% |
| 2011 | 1.83x | CN¥708.20 Million | CN¥387.80 Million | ▲ +30.5% |
| 2010 | 1.40x | CN¥633.30 Million | CN¥452.49 Million | ▲ +45.3% |
| 2009 | 0.96x | CN¥494.88 Million | CN¥513.79 Million | ▼ -79.7% |
| 2008 | 4.73x | CN¥345.18 Million | CN¥72.91 Million | ▲ +896.9% |
| 2007 | 0.47x | CN¥248.55 Million | CN¥523.38 Million | ▼ -68.7% |
| 2006 | 1.52x | CN¥226.46 Million | CN¥149.33 Million | ▲ +9.5% |
| 2005 | 1.39x | CN¥161.07 Million | CN¥116.27 Million | ▲ +2.9% |
| 2004 | 1.35x | CN¥181.46 Million | CN¥134.74 Million | ▼ -45.5% |
| 2003 | 2.47x | CN¥300.01 Million | CN¥121.47 Million | ▼ -0.2% |
| 2002 | 2.48x | CN¥213.65 Million | CN¥86.32 Million | ▲ +19.2% |
| 2001 | 2.08x | CN¥155.15 Million | CN¥74.71 Million | ▲ +39.7% |
| 2000 | 1.49x | CN¥38.52 Million | CN¥25.90 Million | ▼ -94.5% |
| 1999 | 27.25x | CN¥246.23 Million | CN¥9.04 Million | ▲ +6209.8% |
| 1998 | -0.45x | CN¥-18.21 Million | CN¥40.83 Million | — |